"Alchemy of Souls: Light and Shadow" Achieves Its Highest Rating

The fantasy K-drama "Alchemy of Souls Part 2" achieved its highest rating of the season. The show garnered an average nationwide viewership of 8.60% for its 8th episode on January 1 - the highest it has achieved since the season's premiere. The rating for the 7th episode is 6.64%, which gives the series an average rating of 7.62% for the last week. 

Despite the single-digit ratings, the K-drama has been creating buzz ever since its premiere and is winning the hearts of international fans. 

The show has only two more episodes left in its season. And there has been no official statement about the show's return with a third part, yet. 

When and where to watch the K-drama "Alchemy of Souls Part 2"?

The drama airs every Saturday and Sunday. It is available to stream on Netflix. 

The SBS drama "The First Responders" concluded its first season on December 30. And the last episode of the K-drama brought the show its highest ratings of all time of 10.3% (nationwide) and 10.9% (Seoul). The average viewership of the entire drama is 8.5%. 

After the successful conclusion of the first season, the K-drama is reported to return with a second season in the second half of 2023. 

Where to watch "The First Responders"?

All the episodes of "The First Responders" are available on Disney+Hotstar. 

Meanwhile, the viewership of the family K-drama "Three Bold Siblings" plummeted to 9.8% for its 29th episode on December 31. It is the first time the show has got a single-digit rating since its premiere. 

But, the series quickly hopped back to its usual double-digit ratings by getting an average nationwide viewership of 22.8% on January 1 for its 30th episode. The show's average viewership for the last week is 16.3%, and its highest rating is 23.5% (December 25). 

The KBS drama is expected to release 50 episodes. 

When and where to watch the K-drama "Three Bold Siblings"?

"Three Bold Siblings" airs every Saturday and Sunday. The drama is available to watch on Viki.